Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMC 2195957)

Published in J Exp Med on September 17, 2001

Authors

J Hernandez1, S Aung, W L Redmond, L A Sherman

Author Affiliations

1: Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Articles citing this

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med (2002) 6.56

Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med (2003) 5.23

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med (2004) 5.07

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med (2003) 4.64

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med (2002) 3.35

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J Exp Med (2004) 2.89

Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med (2010) 2.44

Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med (2004) 2.43

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med (2005) 2.28

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood (2012) 1.95

Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89

Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest (2007) 1.75

Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol (2013) 1.70

Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J Immunol (2009) 1.60

Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res (2009) 1.49

Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44

Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J Clin Invest (2006) 1.40

Diversity in CD8(+) T cell differentiation. Curr Opin Immunol (2009) 1.32

The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood (2009) 1.27

The instructive role of dendritic cells on T-cell responses. Arthritis Res (2002) 1.26

Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer. Cancer Res (2008) 1.25

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J Immunol (2004) 1.21

CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J Exp Med (2008) 1.14

Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res (2008) 1.10

Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J Immunol (2009) 1.10

Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol (2007) 1.08

Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells. J Immunother (2009) 1.08

Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions. Proc Natl Acad Sci U S A (2008) 1.06

CD40 ligation reverses T cell tolerance in acute myeloid leukemia. J Clin Invest (2013) 1.04

Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. Eur J Immunol (2009) 1.03

Retracted High-avidity T cells are preferentially tolerized in the tumor microenvironment. Cancer Res (2012) 1.01

Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology (2006) 0.97

IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol (2008) 0.95

Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation. J Immunol (2008) 0.93

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Mol Ther (2009) 0.92

Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. Diabetes (2010) 0.91

Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. PLoS One (2014) 0.88

CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J Immunol (2008) 0.86

Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance. Proc Natl Acad Sci U S A (2009) 0.85

TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors. J Clin Invest (2016) 0.85

Dynamics of dendritic cell-T cell interactions: a role in T cell outcome. Semin Immunopathol (2010) 0.84

Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent. Cell Mol Immunol (2011) 0.83

A role for NADPH oxidase in antigen presentation. Front Immunol (2013) 0.83

Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance. J Leukoc Biol (2014) 0.82

Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice. Cancer Immunol Res (2014) 0.81

Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets. Front Immunol (2015) 0.81

Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy (2014) 0.81

Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model. J Immunol (2016) 0.80

Antigen presentation by dendritic cells in vivo. J Exp Med (2002) 0.80

Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol (2014) 0.80

Regulation of T-cell Tolerance by Lymphatic Endothelial Cells. J Clin Cell Immunol (2014) 0.79

Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment. PLoS One (2015) 0.79

Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe? Diabetes (2009) 0.79

CD8+ T cell exhaustion during persistent viral infection is regulated independently of the virus-specific T cell receptor. Immunol Invest (2013) 0.79

Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity. Curr Immunol Rev (2005) 0.79

Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci. Front Genet (2016) 0.78

Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo. Immunology (2006) 0.78

CD8+ clonality is associated with prolonged acute plasma viremia and altered mRNA cytokine profiles during the course of feline immunodeficiency virus infection. Vet Immunol Immunopathol (2012) 0.76

Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice. PLoS One (2015) 0.75

Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes. PLoS One (2017) 0.75

Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation. PLoS One (2014) 0.75

FOXO3 is differentially required for CD8(+) T-cell death during tolerance versus immunity. Immunol Cell Biol (2016) 0.75

Articles cited by this

T cell tolerance by clonal elimination in the thymus. Cell (1987) 13.83

Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55

CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med (1995) 9.79

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77

A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (1983) 8.20

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell (1990) 6.33

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity (1995) 5.77

The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med (2000) 5.62

Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol (2001) 5.15

A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med (1993) 4.99

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97

Phagocyte recognition of cells undergoing apoptosis. Immunol Today (1993) 4.77

Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61

Peripheral selection of the T cell repertoire. Science (1991) 4.56

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med (2000) 4.54

Cutting edge: naive T cells masquerading as memory cells. J Immunol (2000) 4.27

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity (1994) 4.26

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med (1994) 3.66

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med (1996) 3.66

Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J Immunol (1995) 3.06

CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol (1996) 3.02

Homing of naive, memory and effector lymphocytes. Curr Opin Immunol (1993) 2.93

Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol (1998) 2.73

CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69

CD28-B7 interactions in T-cell activation. Curr Opin Immunol (1994) 2.43

Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med (1999) 2.37

Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity (1995) 2.29

Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity (1997) 2.25

Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol (2000) 2.16

Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity. J Immunol (1998) 2.10

The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity (1996) 2.05

Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J Immunol (2001) 1.96

Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J Immunol (1999) 1.89

Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol (1999) 1.86

Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70

The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev (1998) 1.68

Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J Immunol (1998) 1.68

A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol (1996) 1.67

T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol (1999) 1.64

Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur J Immunol (1996) 1.49

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47

CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo. J Exp Med (1999) 1.44

Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43

Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40

From naive to effector--alterations with aging. Immunol Rev (1997) 1.32

CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol (1999) 1.19

Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J Immunol (2000) 1.18

Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol (1992) 1.09

Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol (1999) 1.03

Articles by these authors

(truncated to the top 100)

Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69

CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol (1996) 3.02

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66

Oscillating behavior of carbohydrate granule formation and dinitrogen fixation in the cyanobacterium Cyanothece sp. strain ATCC 51142. J Bacteriol (1994) 2.48

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med (1991) 2.33

Unicellular, aerobic nitrogen-fixing cyanobacteria of the genus Cyanothece. J Bacteriol (1993) 2.22

Optimal conditions for genetic transformation of the cyanobacterium Anacystis nidulans R2. J Bacteriol (1984) 2.17

Organization and Function of Chlorophyll in Membranes of Cyanobacteria during Iron Starvation. Plant Physiol (1983) 2.13

Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity. J Immunol (1998) 2.10

Targeting p53 as a general tumor antigen. Proc Natl Acad Sci U S A (1995) 2.09

Effect of iron deficiency and iron restoration on ultrastructure of Anacystis nidulans. J Bacteriol (1983) 2.03

Bacterial RNA isolation with one hour centrifugation in a table-top ultracentrifuge. Biotechniques (1990) 1.87

Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol (1999) 1.86

Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83

Classification and nomenclature of viruses of cyanobacteria. Intervirology (1983) 1.83

Transcriptional and translational regulation of nitrogenase in light-dark- and continuous-light-grown cultures of the unicellular cyanobacterium Cyanothece sp. strain ATCC 51142. J Bacteriol (1997) 1.82

The role of beta 2-microglobulin in peptide binding by class I molecules. Science (1990) 1.80

Isolation and characterization of photosystem I and II membrane particles from the blue-green alga, Synechococcus cedrorum. Biochim Biophys Acta (1978) 1.80

Blood component recalls in the United States. Transfusion (1999) 1.73

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J Exp Med (1997) 1.73

Chlorophyll-protein organization of membranes from the cyanobacterium Anacystis nidulans. Arch Biochem Biophys (1983) 1.69

Metronidazole and the isolation of temperature-sensitive photosynthetic mutants in cyanobacteria. J Bioenerg Biomembr (1980) 1.69

Regulation and sequence of the Synechococcus sp. strain PCC 7942 groESL operon, encoding a cyanobacterial chaperonin. J Bacteriol (1990) 1.64

Recognition of conformational determinants on H-2 by cytolytic T lymphocytes. Nature (1982) 1.56

Construction of a hybrid plasmid capable of replication in the bacterium Escherichia coli and the cyanobacterium Anacystis nidulans. J Bacteriol (1982) 1.56

Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol (1997) 1.55

Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature (1989) 1.52

Serum sickness following streptokinase therapy. AJR Am J Roentgenol (1982) 1.49

The highly abundant chlorophyll-protein complex of iron-deficient Synechococcus sp. PCC7942 (CP43') is encoded by the isiA gene. Plant Physiol (1993) 1.49

Organization of pigment proteins in the photosystem II complex of the cyanobacterium Anacystis nidulans R2. Proc Natl Acad Sci U S A (1985) 1.45

Influence of Iron Deprivation on the Membrane Composition of Anacystis nidulans. Plant Physiol (1984) 1.44

Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43

Specific binding of soluble fibrin to macrophages. J Exp Med (1977) 1.42

The induction of cytolytic T lymphocytes with specificity for p-azophenylarsonate coupled syngeneic cells. J Immunol (1978) 1.42

A redox-responsive regulator of photosynthesis gene expression in the cyanobacterium Synechocystis sp. Strain PCC 6803. J Bacteriol (2000) 1.38

Monoclonal anti-H-2Kb antibodies detect serological differences between H-2Kb mutants. Immunogenetics (1981) 1.36

Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35

A hybrid plasmid is a stable cloning vector for the cyanobacterium Anacystis nidulans R2. J Bacteriol (1983) 1.34

Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte receptor repertoire. J Exp Med (1980) 1.29

Purification and characterization of an iron stress-induced chlorophyll-protein from the cyanobacterium Anacystis nidulans R2. Biochim Biophys Acta (1988) 1.28

Identification of a carotenoid-binding protein in the cytoplasmic membrane from the heterotrophic cyanobacterium Synechocystis sp. strain PCC6714. J Bacteriol (1986) 1.27

Isolation and Characterization of a Carotenoid-Associated Thylakoid Protein from the Cyanobacterium Anacystis nidulans R2. Plant Physiol (1987) 1.27

Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med (1998) 1.26

Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc Natl Acad Sci U S A (1991) 1.25

Deletion mutagenesis in Synechocystis sp. PCC6803 indicates that the Mn-stabilizing protein of photosystem II is not essential for O2 evolution. Biochemistry (1991) 1.25

Infection of Synechococcus cedrorum by the cyanophage AS-1M. I. Ultrastructure of infection and phage assembly. Virology (1976) 1.24

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J Exp Med (1998) 1.22

DNA sequence and regulation of the gene (cbpA) encoding the 42-kilodalton cytoplasmic membrane carotenoprotein of the cyanobacterium Synechococcus sp. strain PCC 7942. J Bacteriol (1989) 1.21

Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J Immunol (2000) 1.18

Hospital-based study of severe malaria and associated deaths in Myanmar. Bull World Health Organ (1999) 1.18

Recognition of influenza-infected cells by cytolytic T lymphocyte clones: determinant selection by class I restriction elements. J Immunol (1983) 1.18

Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet (1978) 1.17

Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Appl Environ Microbiol (1986) 1.16

Studies on the mechanism of enzymatic DNA elongation by Escherichia coli DNA polymerase II. J Mol Biol (1976) 1.16

Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol (2000) 1.16

Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis (1989) 1.15

Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J Exp Med (1982) 1.14

Membrane Development in the Cyanobacterium, Anacystis nidulans, during Recovery from Iron Starvation. Plant Physiol (1985) 1.14

Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J Immunol (2001) 1.12

Chlorophyll-protein composition of the thylakoid membrane from Prochlorothrix hollandica, a prokaryote containing chlorophyll b. Eur J Biochem (1987) 1.12

Genetic linkage of the cytolytic T lymphocyte repertoire and immunoglobulin heavy chain genes. J Exp Med (1982) 1.11

The composition of the T cell receptor repertoire in nude mice. J Immunol (1987) 1.11

Organization of the thylakoid membrane from the heterotrophic cyanobacterium, Aphanocapsa 6714. Biochim Biophys Acta (1985) 1.10

Nucleotide sequence of the gene from the cyanobacterium Anacystis nidulans R2 encoding the Mn-stabilizing protein involved in photosystem II water oxidation. Proc Natl Acad Sci U S A (1987) 1.10

Pattern of cyanophycin accumulation in nitrogen-fixing and non-nitrogen-fixing cyanobacteria. Arch Microbiol (2001) 1.10

LPP-1 infection of the blue-green alga Plectonema boryanum. I. Electron microscopy. J Virol (1970) 1.08

Infection of Synechococcus cedrorum by the cyanophage AS-1M. III. Cellular metabolism and phage development. Virology (1976) 1.08

The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire. J Immunol (2000) 1.06

Cloning, nucleotide sequence, and mutagenesis of a gene (irpA) involved in iron-deficient growth of the cyanobacterium Synechococcus sp. strain PCC7942. J Bacteriol (1988) 1.05

Infection of Synechococcus cedrorum by the cyanophage AS-1M. II. Protein and DNA synthesis. Virology (1976) 1.04

A Highly Active Oxygen-Evolving Photosystem II Preparation from the Cyanobacterium Anacystis nidulans. Plant Physiol (1984) 1.04

Triton X-114 phase fractionation of membrane proteins of the cyanobacterium Anacystis nidulans R2. Arch Biochem Biophys (1984) 1.02

Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. J Immunol (1989) 1.02

Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. J Immunol (1999) 1.02

Isolation and characterization of a cyanophage infecting the unicellular blue-green algae A. nidulans and S. cedrorum. Virology (1976) 1.01

Phycobilisome-associated glycoproteins in the cyanobacterium Anacystis nidulans R 2. FEBS Lett (1987) 1.01

Identification of iron-responsive, differential gene expression in the cyanobacterium Synechocystis sp. strain PCC 6803 with a customized amplification library. J Bacteriol (2000) 1.01

Transcriptional and translational regulation of photosystem I and II genes in light-dark- and continuous-light-grown cultures of the unicellular cyanobacterium Cyanothece sp. strain ATCC 51142. J Bacteriol (1998) 1.00

Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes. J Exp Med (1982) 1.00

Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation (1980) 1.00

T-cell and B-cell responses to viral antigens at the clonal level. Annu Rev Immunol (1983) 0.99

Macromolecular complexes formed as the result of chloramine-T radioiodination of proteins. Int J Appl Radiat Isot (1974) 0.99

Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur J Immunol (1991) 0.99

Oxygen yield and thermoluminescence characteristics of a cyanobacterium lacking the manganese-stabilizing protein of photosystem II. Biochemistry (1992) 0.99

Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. J Infect Dis (1989) 0.99

Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J Exp Med (1994) 0.98

CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen. J Immunol (2001) 0.98

Promotion of insecticide-treated mosquito nets in Myanmar. Southeast Asian J Trop Med Public Health (2000) 0.97

Human CD8 transgene regulation of HLA recognition by murine T cells. J Exp Med (1995) 0.96

Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes. J Immunol (1989) 0.96

LPP-1 infection of the blue-green alga Plectonema boryanum. II. Viral deoxyribonucleic acid synthesis and host deoxyribonucleic acid breakdown. J Virol (1970) 0.95

Improved 5-step modeling of the Photosystem II S-state mechanism in cyanobacteria. Photosynth Res (1996) 0.95

Cytolytic T-lymphocyte response to isolated class I H-2 proteins and influenza peptides. Nature (1989) 0.95

Clinical significance of anti-At(a). Vox Sang (1995) 0.95

LPP-1 infection of the blue-green alga Plectonema boryanum. 3. Protein synthesis. J Virol (1970) 0.94

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8. Hum Immunol (1997) 0.94

Indium-III: a new radionuclide label for studying human platelet kinetics. Br J Haematol (1979) 0.94

Immunological Characterization of Iron-Regulated Membrane Proteins in the Cyanobacterium Anacystis nidulans R2. Plant Physiol (1988) 0.91

Fibronectin: blood turnover in normal animals and during intravascular coagulation. Blood (1982) 0.91

Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation (1985) 0.91